Infectious diseases impose a significant burden on global health systems due to high morbidity and mortality rates. According to the World Health Organization, millions die from infectious diseases annually, often due to delays in accurate diagnosis. Traditional diagnostic methods in clinical microbiology, primarily culture-based techniques, are time-consuming and may fail with hard-to-culture pathogens. Molecular biology advancements, notably the polymerase chain reaction (PCR), have revolutionized infectious disease diagnostics by allowing rapid and sensitive detection of pathogens’ genetic material. PCR has become the gold standard for many infections, particularly highlighted during the COVID-19 pandemic. Following PCR, next-generation sequencing (NGS) has emerged, enabling comprehensive genomic analysis of pathogens, thus facilitating the detection of new strains and antibiotic resistance tracking. Innovative approaches like CRISPR technology are also enhancing diagnostic precision by identifying specific DNA/RNA sequences. However, the implementation of these methods faces challenges, particularly in low- and middle-income countries due to infrastructural and financial constraints. This review will explore the role of molecular diagnostic methods in infectious disease diagnosis, comparing their advantages and limitations, with a focus on PCR and NGS technologies and their future potential.
Klebsiella pneumoniae is an opportunistic Gram-negative bacterium in the Enterobacteriaceae family associated with a wide range of diseases, such as pneumonia, bloodstream infections, meningitis and urinary tract infections. Infections caused by drug-resistant strains of Klebsiella pneumoniae pose a significant threat to the effectiveness of conventional antibiotics. Hence, this has led to the need to explore alternative antimicrobial therapies, especially natural products derived from plant sources. This study assessed the phytochemical composition and antibacterial properties and performed a molecular docking analysis of Henna leaves (Lawsonia inermis L.) extracts on strains of Klebsiella pneumoniae. Crude ethanol and methanol extracts of L. inermis L. were prepared at different concentrations (25, 50, 75 and 100 mg/mL) and tested on extended spectrum beta-lactamases (ESBLs)-producing strains of Klebsiella pneumoniae. Phytocompounds were identified using gas chromatography–mass spectrometry (GC-MS) and further subjected to virtual ligands screening with DataWarrior (v05.02.01) and a molecular docking analysis using AutoDock4.2 (v4.2.6). The active compounds of L. inermis L. were determined by the docking analysis, including phytochemical, physicochemical, pharmacokinetics and docking score. The GC-MS analysis identified 27 phytoconstituents, including ethyl acetate, sclareol, 2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine, α-bisabolol and 2-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate. The 27 compounds were then screened for their physicochemical and pharmacokinetic properties. The results revealed that the methanol extracts at 100 mg/mL showed significantly higher (p < 0.05) zones of inhibition (13.7 ± 1.2 mm), while the ethanol extracts at 50 mg/mL were significantly lower (6.3 ± 0.6 mm) compared to all the other treatments. The docking analysis revealed that out of the 27 compounds identified, only twelve (12) compounds have a drug-likeness activity. The 12 compounds were further subjected to docking analysis to determine the binding energies with the CTX-M protein of Klebsiella pneumoniae. Only one compound [CID_440869; (2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine)] had the best binding energy of −9.76 kcal/mol; hence, it can be considered a potentially suitable treatment for infections caused by ESBLs-producing strains of Klebsiella pneumoniae. This study has demonstrated that L. inermis L. extracts have antibacterial effects. Further research could explore the potential antimicrobial applications of L. inermis L. extracts to many bacterial strains.
Infectious diseases impose a significant burden on global health systems due to high morbidity and mortality rates. According to the World Health Organization, millions die from infectious diseases annually, often due to delays in accurate diagnosis. Traditional diagnostic methods in clinical microbiology, primarily culture-based techniques, are time-consuming and may fail with hard-to-culture pathogens. Molecular biology advancements, notably the Polymerase Chain Reaction (PCR), have revolutionized infectious disease diagnostics by allowing rapid and sensitive detection of pathogens' genetic material. PCR has become the gold standard for many infections, particularly highlighted during the COVID-19 pandemic. Following PCR, Next-Generation Sequencing (NGS) has emerged, enabling comprehensive genomic analysis of pathogens, thus facilitating the detection of new strains and antibiotic resistance tracking. Innovative approaches like CRISPR technology are also enhancing diagnostic precision by identifying specific DNA/RNA sequences. However, the implementation of these methods faces challenges, particularly in low- and middle-income countries due to infrastructural and financial constraints. This review will explore the role of molecular diagnostic methods in infectious disease diagnosis, comparing their advantages and limitations, with a focus on PCR and NGS technologies and their future potential.
Presence of Bacterial contamination in hospital environments, particularly intensive care units, poses a serious threat to global public health in the world with high morbidity and mortality rates. Of more concern is the emergence of multidrug-resistant bacteria on medical devices, inanimate surfaces, health care providers, and patients in the intensive care unit, which could lead to further cross-contamination and infection. This study aimed to assess the bacterial profile and their antimicrobial susceptibility patterns of bacterial isolates from the intensive care unit of the Emergency unit, internal medicine, and coronary unit of Misurata Central Unit of Misurata, Libya. A unit-based cross-sectional study was conducted on three Intensive Care units from 1st December 2024 to 27th December 2024. In this project, a total of 102 swab samples from the intensive care unit environment were collected using cotton swabs. Standard Microbiological techniques to include culture method and Gram stain, were employed for the identification of the isolates. Antimicrobial susceptibility tests for bacterial isolates were performed by using the Kirby-Bauer disk diffusion method. In the total of 102 swab samples, bacterial growth was observed in 19.6% (20/102) of the total samples. Out of the total bacterial growth recovered, the Coronary care unit had the highest, 50% (10/20), followed by the Emergency unit 35% (7/20), and the Internal medicine unit had 15% (3/20). The most frequently found isolate was Staphylococcus aureus 75% (15/20), followed by Streptococcus pyogenes 15% (3/20), Pseudomonas aeruginosa 5% (1/20), and E coli 5% (1/20). Results of the antibiotic susceptibility pattern revealed that most of the isolates are multidrug-resistant. Results from this study showed bacterial contamination of the ICU environments and their resistance patterns, which suggest that patients are prone to hospital-associated infection. It is recommended that strict sterilization of intensive care units be standardized and the hygiene of hospital workers be enforced to prevent transmission of infection in hospital environments.
The high increase in diarrhea cases draws the attention of microbiologists to take the necessary precautions against the epidemic that occurs in some regions. It has been found that each year, the mortality and morbidity rates of this infection account for about 500,000 cases in the United States. This retrospective study focuses on the investigation of the rate of C. difficile in a university hospital. Clostridium difficile toxin A / B results of patients admitted to the North Cyprus Near East University hospital between 2015-2018 were retrospectively extracted from the hospital registry system. A total of 230 patient data were used in the study. Data variables used included demographic information, department, and inpatient or outpatient treatment. No significant difference was found in the age category in terms of Clostridium difficile toxin A / B positivity (p = 0.822). The highest positive C. difficile toxin A / B ratio was found in 18.2% in the 20-44 age group, while it was 15.5% in the age group 45 and over. However, there was no statistically significant difference in the age group, as the chi-square result gave a p-value = 0.721. The distribution of this infection showed statistical significance between inpatients and outpatients with a p-value of 0.018. While 9.70% of positivity was detected in inpatients, it was 21.30% in outpatients. The high rate of C. difficile infection among outpatients is due to the unregulated guidelines in the use of antibiotics obtained from pharmaceutical stores. This study shows the inadequacy of rational use of antibiotics in practice, although the sale of antibiotics without a prescription is prohibited in Northern Cyprus.
26 October 2026 in AlQalam Journal of Medical and Applied Sciences
Atherogenic dyslipidemia, characterized by elevated triglyceride (TG) levels and reduced high-density lipoprotein cholesterol (HDL-C), is closely associated with insulin resistance and an unfavorable cardiometabolic profile. The atherogenic index of plasma (AIP), calculated as the logarithm of the TG-to-HDL-C ratio, integrates these lipid parameters into a single indicator of atherogenic risk. This study aimed to evaluate the discriminatory performance of AIP and other lipid parameters in distinguishing individuals with HbA1c >6.5% from those with HbA1c ≤6.5%. The supplied study results included 200 adults divided into two equal groups according to HbA1c: 100 participants with HbA1c ≤6.5% and 100 with HbA1c >6.5%. Lipid measurements were obtained after a 12-hour fast. Receiver operating characteristic (ROC) analysis and the Youden index were used to assess discrimination and identify cut-off values. Mean age was 45.26 ± 10.71 years; 59% were female. AIP had the highest reported area under the ROC curve (AUC = 0.825, 95% CI: 0.765–0.883; p < 0.001). The reported optimal AIP cut-off was >0.145, with 78.0% sensitivity and 74.7% specificity. TG also showed good discrimination (AUC = 0.791, 95% CI: 0.728–0.854; p < 0.001), whereas total cholesterol (AUC = 0.682), LDL-C (AUC = 0.645), and HDL-C (AUC = 0.312) showed weaker or directionally inverse discrimination. Conclusion: This study highlights the potential value of AIP as an adjunctive marker for identifying an atherogenic lipid profile associated with elevated HbA1c. AIP should be interpreted as a complementary cardiometabolic indicator rather than a replacement for established glycemic assessment methods.